Be Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BE PHARMS, and what generic and branded alternatives to BE PHARMS drugs are available?
BE PHARMS has eleven approved drugs.
Drugs and US Patents for Be Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Be Pharms | PANTOPRAZOLE SODIUM | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 216171-001 | May 18, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-006 | Jun 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-003 | Jun 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-005 | Jun 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Be Pharms | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 217521-002 | Jun 26, 2023 | AP2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.